[Adjuvant therapy of breast cancer]

Khirurgiia (Mosk). 2001:(5):52-60.
[Article in Russian]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adult
  • Age Factors
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / radiotherapy
  • Breast Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Cisplatin / therapeutic use
  • Combined Modality Therapy
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / therapeutic use
  • Goserelin / administration & dosage
  • Goserelin / therapeutic use
  • Humans
  • Lymph Node Excision
  • Lymphatic Metastasis
  • Mastectomy
  • Methotrexate / therapeutic use
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Ovariectomy
  • Postoperative Care
  • Preoperative Care
  • Prognosis
  • Risk Factors
  • Tamoxifen / administration & dosage
  • Tamoxifen / therapeutic use

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Antineoplastic Agents, Hormonal
  • Tamoxifen
  • Goserelin
  • Cisplatin
  • Fluorouracil
  • Methotrexate

Supplementary concepts

  • CMF protocol